Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay

scientific article published on 21 September 2016

Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.OPHTHA.2016.07.028
P8608Fatcat IDrelease_u4q7du2njfhpljcmna3hxl5qou
P698PubMed publication ID27665213

P50authorAnselm KampikQ26678533
P2093author name stringElisabeth M Messmer
Alexandra Garbe
Victoria von Lindenfels
P433issue11
P921main subjecteye diseaseQ3041498
P304page(s)2300-2308
P577publication date2016-09-21
P1433published inOphthalmologyQ7098109
P1476titleMatrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay
P478volume123

Reverse relations

cites work (P2860)
Q90615647A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain
Q46718255Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease
Q92824372Dry Eye Disease: A Review of Epidemiology in Taiwan, and its Clinical Treatment and Merits
Q90079719Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy
Q58588885Dry eye disease: when to treat and when to refer
Q92127985Effect of Topical Prostaglandin F2α Analogs on Selected Oxidative Stress Parameters in the Tear Film
Q33686685Effect of thermal pulsation treatment on tear film parameters in dry eye disease patients
Q90529029Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines
Q99551257In vitro validation of the tear matrix metalloproteinase 9 in-situ immunoassay
Q58599953Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease
Q55122175Prevalence and clinical characteristics of dry eye disease in community-based type 2 diabetic patients: the Beixinjing eye study.
Q61811294Review of Biomarkers in Ocular Matrices: Challenges and Opportunities
Q47112214Tear proteome analysis in ocular surface diseases using label-free LC-MS/MS and multiplexed-microarray biomarker validation
Q33756582The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research
Q47424328Update in Current Diagnostics and Therapeutics of Dry Eye Disease.
Q52322805[Diagnosis of dry eye disease].

Search more.